CMHC Spring 2021 On Demand

This 2021 CMHC Spring On Demand activity will highlight the latest updates in hypertension, heart failure, diabetes, dyslipidemia, lifestyle management, cardiovascular health, as well as the impacts of COVID-19 on cardiometabolic health, and translate the latest cutting-edge medical research into practical, clinical strategies for preventing, delaying, and managing cardiovascular and metabolic disorders.

To view recordings from PME Symposia, please visit the PME Library located here

Target Audience

US-based healthcare professionals, including cardiologists, endocrinologists, lipidologists, primary care clinicians (PCPs), registered nurses, advanced practice registered nurses, dieticians, pharmacists, and other allied health professionals.

Learning Objectives

After completing this activity, the participant should be better able to:

  • Discuss the interrelationships among cardiometabolic risk factors and their impact on the development of cardiometabolic diseases, including diabetes, dyslipidemia, hypertension, obesity, kidney disease, and cardiovascular disease.
  • Interpret the latest evidence and guidelines for the prevention, screening, and treatment of the complex patient with cardiometabolic risk or cardiometabolic disease.
  • Outline strategies aimed at timely screening and prevention of cardiometabolic disease, including biomarkers, imaging, genetic risk assessment, and lifestyle modifications.
  • Develop individualized treatment regimens for patients with cardiometabolic disease based on the efficacy and safety of current and new pharmacotherapies, patient comorbidities and preferences to optimize outcomes.
  • Review therapy for chronic cardiometabolic diseases, including diabetes, CVD, and obesity in the COVID-19 era, as well as incorporate technology and telemedicine when appropriate to ensure the continuum of care for these patients
Course summary
Available credit: 
  • 14.75 ACPE Pharmacy
  • 14.75 AMA PRA Category 1 Credit™
  • 14.75 ANCC
  • 14.75 CDE
  • 14.75 Participation
Course opens: 
05/11/2021
Course expires: 
05/11/2022
Rating: 
0

Robert H. Eckel, MD (Chair)
Professor of Medicine, Emeritus
Division of Endocrinology, Metabolism and Diabetes
Division of Cardiology
Charles A. Boettcher II Chair in Atherosclerosis, Emeritus
University of Colorado Anschutz Medical Campus
Past President, American Heart Association, FAHA, FACC
President of Medicine and Science, American Diabetes Association
Aurora, CO

Christie M. Ballantyne, MD (Chair)
Professor of Medicine
Chief, Section of Cardiovascular Research
Chief, Section of Cardiology
Department of Medicine, Baylor College of Medicine
Director, Center for Cardiovascular Disease Prevention
Baylor College of Medicine
Methodist DeBakey Heart Center
Houston, TX

George L. Bakris, MD (Chair)
Professor of Medicine
Director, ASH Comprehensive Hypertension Center
University of Chicago Medicine
Chicago, IL

Anne L. Peters, MD (Chair)
Professor, Keck School of Medicine
Director, Clinical Diabetes Programs
University of Southern California<
Los Angeles, CA

Deepak L. Bhatt, MD
Executive Director of Interventional Cardiovascular Programs
Brigham and Women’s Hospital Heart & Vascular Center
Professor of Medicine, Harvard Medical School
Boston,  MA

 

Joseph A. Aloi, MD
Chief: Section on Endocrinology and Metabolism
Wake Forest Baptist Health
Winston-Salem, NC

Nicholas B. Argento, MD, FACE
Diabetes Technology Director
Maryland Endocrine and Diabetes Center
Columbia, MD

Vanita R. Aroda, MD
Director, Diabetes Clinical Research
Brigham and Women’s Hospital
Harvard Medical School
Boston, MA

Louis J. Aronne, MD
Sanford I. Weill Professor of Metabolic Research
Medical Director
Center for Weight Management & Metabolic Clinical Research
Weill-Cornell Medical College
New York, NY

Matthew J. Budoff, MD
Professor of Medicine
David Geffen School of Medicine
Program Director & Director of Cardiac CT
Division of CardiologyHarbor-UCLA Medical Center
Torrance, CA

Barto Burguera, MD, PhD
Chairman of Endocrinology and Metabolism Institute (EMI)
Cleveland Clinic
Cleveland, OH

Sarah E. Chuzi, MD
Cardiovascular Diseases Fellow
Northwestern University Feinberg School of Medicine
Chicago, IL

Brendan M. Everett, MD, MPH
Associate Professor, HMS
Director, Impatient General Cardiology
Brigham and Women’s Hospital
Boston, MA

Sarah Hallberg, DO, MS, ACSM-CEP, FOMA, FNLA
Medical Director
Virta Health
San Francisco, CA

Elaine M. Hylek, MD, MPH
Professor of Medicine
Boston University School of Medicine
Boston, MA

Penny Kris-Etherton, PhD
Evan Pugh University Professor of Nutritional Sciences
Distinguished Professor of Nutrition
The Pennsylvania State University
State College, PA

Carl J. Lavie Jr., MD
Professor of Medicine
Medical-Director, Preventive Cardiology
John Ochsner Heart and Vascular Inst.
Ochsner Clinical School-The UQ School of Medicine
New Orleans, LA

Alanna A. Morris, MD, MSc
Assistant Professor of Medicine
Emory University School of Medicine
Atlanta, GA

Pamela B. Morris, MD
Director, Seinsheimer Cardiovascular Health Program
Co-Director, Women’s Heart Care
Medical University of South Carolina
Charleston, SC

Margo Minissian, PhD, ACNP
Nurse Scientist
Cardiology Nurse Practitioner
Clinical Lipid Specialist
Barbra Streisand Women’s Heart Center, Cedars-Sinai Heart Institute
Los Angeles, CA

Aldo J. Peixoto, MD
Professor of Medicine
Vice Chair for Quality and Safety (Dept of Internal Medicine)
Clinical Chief (Section of Nephrology)
Yale School of Medicine
New Haven, CT

Ileana L. Piña, MD, MPH, FAHA, FACC
Professor of Medicine, Wayne State University
Clinical Professor of Medicine
Central Michigan University
Mount Pleasant, MI

Jane Reusch, MD
Professor of Medicine and Integrative Physiology
University of Colorado SOM
Aurora, CO

Donna H. Ryan, MD
Professor Emerita
Interim Executive Director
Pennington Biomedical Research Center
New Orleans, LA

Viral N. Shah, MD
Associate Professor of Medicine & Pediatrics, Barbara Davis Center
for Diabetes
University of Colorado Anschutz Medical Campus
Aurora, CO

Daichi Shimbo, MD
Professor of Medicine
Columbia University Irving Medical Center
New York, NY

Jay H. Shubrook, DO, FACOFP, FAAFP
Professor, Primary Care Department
Touro University California College of Osteopathic Medicine
Vallejo, CA

Ahmed M. Soliman, MD
Associate Medical Director
Houston Methodist DeBakey Cardiology Associates
Houston, TX

Joseph Vassalotti, MD
Clinical Professor - Icahn School of Medicine at Mount Sinai
Chief Medical Officer – National Kidney Foundation
New York, NY

Kim A. Williams, Sr., MD
James B. Herrick Professor
Chief, Division of Cardiology
Editor-in-Chief, International Journal of Disease Reversal and Prevention
Rush University Medical Center
Chicago, IL

Stephen D. Wiviott, MD, FACC
Associate Professor of Medicine, Harvard Medical School
Vice President for Clinical Trials Research and Administration
Senior Investigator, TIMI Study Group
Mass General Brigham
Boston, MA

William F. Young, Jr., MD, MSc
Professor of Medicine
Mayo Clinic
Rochester, MN

 

 

ESTIMATED TIME TO COMPLETE ACTIVITY
14.75 hours

JOINT ACCREDITATION STATEMENT
image   image   image



In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Tarsus Cardio Inc. dba Cardiometabolic Health Congress (CMHC). Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CONTINUING MEDICAL EDUCATION
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 14.75 AMA PRA Category 1 Credits™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

CONTINUING NURSING EDUCATION
The maximum number of hours awarded for this Continuing Nursing Education activity is 14.75 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate. 

CONTINUING PHARMACY EDUCATION
Postgraduate Institute for Medicine designates this continuing education activity for 14.75 contact hour(s) (1.475 CEUs) of the Accreditation Council for Pharmacy Education.

This is an application-based activity. Universal Activity Numbers (UAN): # JA4008162-9999-21-2768-H01-P.

For Pharmacists: Upon completing the post-test and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 – 6 weeks.

CONTINUING DIETICIAN EDUCATION
This program offers 14.75 CPEUs for dieticians.

ABIM MOC CERTIFICATION
image
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 14.75 MOC points in the American Board of Internal Medicine's (ABIM) maintenance of certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty
A full listing of faculty disclosures  can be downloaded here.

Planners and Managers
The PIM planners and managers have nothing to disclose. The CMHC planners and managers have nothing to disclose.

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

METHOD OF PARTICIPATION & REQUEST FOR CREDIT
There are no registration fees for this activity. During the period May 11, 2021 through May 11, 2022, participants must read the learning objectives and faculty disclosures, study the educational activity, and complete the evaluation. Upon completing, your certificate will be available for print. For questions about receiving certificates, please contact us at CMHC_Eval@cardiometabolichealth.org.

For questions about the accreditation of this activity, please visit www.pimed.com.

For Pharmacists: Please complete the evaluation instructions above. Upon registering and completing the activity evaluation, your transcript information will be sent to the NABP CPE Monitor Service within 4-6 weeks.

Available Credit

  • 14.75 ACPE Pharmacy
  • 14.75 AMA PRA Category 1 Credit™
  • 14.75 ANCC
  • 14.75 CDE
  • 14.75 Participation
Please login or register to take this course.

There are no registration fees for this activity. Please enroll and proceed with the course instructions.

Required Hardware/software

A computer with an internet connection

Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser

Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.